René Opavský

3.3k total citations
41 papers, 2.2k citations indexed

About

René Opavský is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, René Opavský has authored 41 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Genetics. Recurrent topics in René Opavský's work include Epigenetics and DNA Methylation (19 papers), Cancer-related gene regulation (11 papers) and Cancer-related Molecular Pathways (8 papers). René Opavský is often cited by papers focused on Epigenetics and DNA Methylation (19 papers), Cancer-related gene regulation (11 papers) and Cancer-related Molecular Pathways (8 papers). René Opavský collaborates with scholars based in United States, Slovakia and Czechia. René Opavský's co-authors include Silvia Pastoreková, Vladimı́r Zelnı́k, Jaromı́r Pastorek, Gustavo Leone, Jaromı́r Pastorek, Richard Kettmann, Adriana Gibadulinová, Shengyou Liao, E. Stanbridge and Daniel Portetelle and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

René Opavský

41 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
René Opavský United States 21 1.8k 554 485 259 187 41 2.2k
Rosaria Gangemi Italy 25 1.1k 0.6× 391 0.7× 760 1.6× 275 1.1× 164 0.9× 52 2.2k
Steven J. Freedman United States 16 1.1k 0.6× 656 1.2× 425 0.9× 104 0.4× 111 0.6× 28 2.1k
Igor Kuzmin United States 20 1.5k 0.8× 722 1.3× 313 0.6× 61 0.2× 344 1.8× 26 1.9k
Michael Zinda United States 22 935 0.5× 188 0.3× 469 1.0× 128 0.5× 192 1.0× 37 1.4k
Yi‐Mi Wu United States 10 1.9k 1.1× 1.2k 2.1× 361 0.7× 63 0.2× 297 1.6× 44 2.5k
Jacqueline M. Mason Canada 17 1.2k 0.7× 224 0.4× 475 1.0× 89 0.3× 188 1.0× 22 1.7k
Joseph Gera United States 28 2.4k 1.4× 396 0.7× 592 1.2× 78 0.3× 221 1.2× 60 3.0k
W. Clay Gustafson United States 19 1.6k 0.9× 456 0.8× 487 1.0× 28 0.1× 342 1.8× 38 2.3k
Joan Levy United States 28 2.6k 1.5× 406 0.7× 955 2.0× 71 0.3× 241 1.3× 58 3.6k
L. Geil United States 14 1.1k 0.6× 429 0.8× 214 0.4× 61 0.2× 249 1.3× 27 1.3k

Countries citing papers authored by René Opavský

Since Specialization
Citations

This map shows the geographic impact of René Opavský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René Opavský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René Opavský more than expected).

Fields of papers citing papers by René Opavský

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by René Opavský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René Opavský. The network helps show where René Opavský may publish in the future.

Co-authorship network of co-authors of René Opavský

This figure shows the co-authorship network connecting the top 25 collaborators of René Opavský. A scholar is included among the top collaborators of René Opavský based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with René Opavský. René Opavský is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lopušná, Katarína, Jana Opavska, Duo Chen, et al.. (2024). Genome-Wide Methylation Profiling of Peripheral T–Cell Lymphomas Identifies TRIP13 as a Critical Driver of Tumor Proliferation and Survival. Epigenomes. 8(3). 32–32. 1 indexed citations
2.
Morozov, Viacheslav, et al.. (2024). Overcoming ABCB1 mediated multidrug resistance in castration resistant prostate cancer. Cell Death and Disease. 15(8). 558–558. 7 indexed citations
3.
Lopušná, Katarína, et al.. (2021). Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling. EBioMedicine. 63. 103191–103191. 8 indexed citations
4.
Lopušná, Katarína, Jana Opavska, Staci L. Haney, et al.. (2019). Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions. Nature Communications. 10(1). 4374–4374. 26 indexed citations
5.
Haney, Staci L., et al.. (2016). Aberrant Promoter Hypomethylation in CLL: Does It Matter for Disease Development?. Frontiers in Oncology. 6. 182–182. 15 indexed citations
6.
Haney, Staci L., Jana Opavska, David Klinkebiel, et al.. (2016). Promoter Hypomethylation and Expression Is Conserved in Mouse Chronic Lymphocytic Leukemia Induced by Decreased or Inactivated Dnmt3a. Cell Reports. 15(6). 1190–1201. 28 indexed citations
7.
Haney, Staci L., Jana Opavska, David Klinkebiel, et al.. (2016). Dnmt3a Is a Haploinsufficient Tumor Suppressor in CD8+ Peripheral T Cell Lymphoma. PLoS Genetics. 12(9). e1006334–e1006334. 32 indexed citations
8.
Haney, Staci L., Jana Opavska, David Klinkebiel, et al.. (2016). Loss of Dnmt3a induces CLL and PTCL with distinct methylomes and transcriptomes in mice. Scientific Reports. 6(1). 34222–34222. 12 indexed citations
9.
Haney, Staci L., Ryan A. Hlady, Jana Opavska, et al.. (2015). Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis. Oncogene. 34(43). 5436–5446. 20 indexed citations
10.
Opavský, René, et al.. (2015). Absence of caveolin-1 leads to delayed development of chronic lymphocytic leukemia in Eμ-TCL1 mouse model. Experimental Hematology. 44(1). 30–37.e1. 5 indexed citations
11.
Lin, Wan-Chi, Nirakar Rajbhandari, Chengbao Liu, et al.. (2013). Dormant Cancer Cells Contribute to Residual Disease in a Model of Reversible Pancreatic Cancer. Cancer Research. 73(6). 1821–1830. 60 indexed citations
12.
Trikha, Prashant, Nidhi Sharma, René Opavský, et al.. (2010). E2f1–3 Are Critical for Myeloid Development. Journal of Biological Chemistry. 286(6). 4783–4795. 27 indexed citations
13.
Tsai, Shih‐Yin, René Opavský, Nidhi Sharma, et al.. (2008). Mouse development with a single E2F activator. Nature. 454(7208). 1137–1141. 74 indexed citations
14.
Opavský, René, Shu‐Huei Wang, Prashant Trikha, et al.. (2007). CpG Island Methylation in a Mouse Model of Lymphoma Is Driven by the Genetic Configuration of Tumor Cells. PLoS Genetics. 3(9). e167–e167. 34 indexed citations
15.
Chen, Danian, René Opavský, Marek Pacal, et al.. (2007). Rb-Mediated Neuronal Differentiation through Cell-Cycle–Independent Regulation of E2f3a. PLoS Biology. 5(7). e179–e179. 76 indexed citations
16.
Yu, Li, Chunhui Liu, Kristi L. Bennett, et al.. (2004). A NotI–EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies. Genomics. 84(4). 647–660. 20 indexed citations
17.
Opavský, René, Peter Haviernik, Dana Jurkovičová, et al.. (2001). Molecular Characterization of the MouseTem1/endosialin Gene Regulated by Cell Density in Vitro and Expressed in Normal Tissues in Vivo. Journal of Biological Chemistry. 276(42). 38795–38807. 57 indexed citations
18.
Nicot, Christophe, Renaud Mahieux, René Opavský, et al.. (2000). HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300. Oncogene. 19(17). 2155–2164. 34 indexed citations
19.
Nicot, Christophe, René Opavský, Renaud Mahieux, et al.. (2000). Tax Oncoprotein trans -Represses Endogenous B- myb Promoter Activity in Human T Cells. AIDS Research and Human Retroviruses. 16(16). 1629–1632. 19 indexed citations
20.
Kabát, Peter, Michael Tristem, René Opavský, & Jaromı́r Pastorek. (1996). Human Endogenous Retrovirus HC2 Is a New Member of the S71 Retroviral Subgroup with a Full-LengthpolGene. Virology. 226(1). 83–94. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosaria Gangemi Breakdown of academic impact, for papers by Steven J. Freedman Breakdown of academic impact, for papers by Igor Kuzmin Breakdown of academic impact, for papers by Michael Zinda Breakdown of academic impact, for papers by Yi‐Mi Wu Breakdown of academic impact, for papers by Jacqueline M. Mason Breakdown of academic impact, for papers by Joseph Gera Breakdown of academic impact, for papers by W. Clay Gustafson Breakdown of academic impact, for papers by Joan Levy Breakdown of academic impact, for papers by L. Geil
Rankless by CCL
2026